FDA U.S. FOOD & DRUG ADMIN.

Drug Listing Form

U.S. Food and Drug Administration · Center for Drug Evaluation and Research (CDER)

Form 2657
Authority21 U.S.C. §360; 21 CFR Part 207 Required ForAll marketed drug products OMB0910-0045 SubmittalBefore marketing & annually
Labeler
Manufacturer
Drug Product
Packaging
DEA / Characteristics
Marketing
Active Ing.
Inactive Ing.
Certification
🏷️
The Labeler name must be identical to the name registered with the NDC Labeler Code. Any discrepancy may result in listing rejection.

🏭
💊
📦

Inner Package


Outer Package


Attach Label Image

🖼️

Click to upload label image

Accepted formats: JPG, PNG, PDF — Max 10MB
⚗️

Characteristics

📊
🔬
# Active Ingredient (e.g. Avobenzone) Strength (e.g. 200mg in 1 mL) UNII (Unique Ingredient Identifier, if known)
Please use an additional form if you have more than 8 active ingredients.
🧪
# Inactive Ingredient (e.g. Water) Strength (Optional) UNII (if known)
Please use an additional form if you have more inactive ingredients than listed. Strength is optional for inactive ingredients.

📋
📜 Terms and Conditions

By submitting this drug listing form, the submitter certifies that:

1. The drug product(s) listed on this form are currently marketed or will be marketed in the United States.

2. All information provided is true and accurate to the best of the submitter's knowledge and belief.

3. The submitter is authorized to submit this listing on behalf of the labeler.

4. The labeler will update this listing whenever any information changes, and will renew annually as required by 21 CFR Part 207.

5. Under 18 U.S.C. §1001, anyone who makes a materially false, fictitious, or fraudulent statement to the U.S. Government is subject to criminal penalties.

6. Drug listing does not constitute FDA approval or clearance of the drug product.

Submitter Information

Listing Submitted

Your FDA Drug Listing has been received successfully. Our team will review your submission and follow up with next steps shortly.